Genenta Science SPA
GNTA3.772USD
-0.048-1.25%
시장 운영 시간 （ET）시세는 15분 지연됩니다
69.00M시가총액
--P/E TTM
자세한 내용은 Genenta Science SPA 회사
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
회사 정보
종목 코드 GNTA
회사 이름Genenta Science SPA
상장일Dec 15, 2021
CEOMr. Pierluigi Paracchi
직원 수13
유형Depository Receipt
회계 연도 종료Dec 15
주소Via Olgettina 58
도시MILANO
증권 거래소NASDAQ Capital Market Consolidated
국가Italy
우편 번호20132
전화
웹사이트https://www.genenta.com/
종목 코드 GNTA
상장일Dec 15, 2021
CEOMr. Pierluigi Paracchi
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
-0.13%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.67%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+11.03%
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
-100.00%
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.30M
-0.13%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.67%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
+11.03%
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Paracchi (Pierluigi)
12.55%
IRCCS Ospedale San Raffaele
10.37%
Naldini (Luigi M.D., Ph.D.)
7.58%
Gentner (Bernard)
3.79%
Russo (Carlo)
3.29%
Other
62.41%
주주
주주
비율
Paracchi (Pierluigi)
12.55%
IRCCS Ospedale San Raffaele
10.37%
Naldini (Luigi M.D., Ph.D.)
7.58%
Gentner (Bernard)
3.79%
Russo (Carlo)
3.29%
Other
62.41%
주주 유형
주주
비율
Individual Investor
27.50%
Corporation
10.37%
Investment Advisor
5.67%
Investment Advisor/Hedge Fund
2.53%
Sovereign Wealth Fund
1.60%
Holding Company
1.28%
Hedge Fund
0.55%
Research Firm
0.02%
Other
50.48%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
24
9.06M
49.52%
-130.50K
2025Q1
28
9.12M
49.85%
-26.40K
2024Q4
28
8.70M
47.57%
-293.74K
2024Q3
26
8.60M
47.05%
-368.88K
2024Q2
26
8.48M
46.40%
-155.29K
2024Q1
25
8.51M
46.63%
+417.20K
2023Q4
25
8.38M
45.98%
+434.51K
2023Q3
24
8.11M
44.52%
+167.75K
2023Q2
24
8.11M
44.52%
+601.69K
2023Q1
18
7.50M
41.20%
+4.74M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Paracchi (Pierluigi)
2.30M
12.55%
-3.10K
-0.13%
Mar 26, 2025
IRCCS Ospedale San Raffaele
1.90M
10.37%
--
--
Mar 26, 2025
Naldini (Luigi M.D., Ph.D.)
1.39M
7.58%
--
--
Mar 26, 2025
Gentner (Bernard)
692.87K
3.79%
--
--
Mar 26, 2025
Russo (Carlo)
602.42K
3.29%
+4.00K
+0.67%
Mar 26, 2025
Eurizon Capital SGR S.p.A.
360.00K
1.97%
--
--
May 31, 2025
Kairos Partners SGR S.p.A.
335.63K
1.84%
-248.00
-0.07%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
292.84K
1.6%
-14.36K
-4.68%
Dec 31, 2024
Investitori SGR S.p.A.
233.55K
1.28%
--
--
May 31, 2025
Allianz SE
233.55K
1.28%
+130.30K
+126.20%
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
